Guhan Subramanian and Rhea Ghosh
January 27, 2011
Click to Purchase
This case series takes from Merck and Johnson & Johnson’s Centocor unit conflict over distribution rights for two arthritis drugs, Remicade and Simponi. This case series allows students to negotiate their own agreement heading into arbitration with specific instructions for both business and legal teams from each organization.
The case series allows participants to apply core concepts such as BATNA, reservation price, and ZOPA, while also requiring them to consider more complex and challenging issues, such as uncertainty surrounding possible arbitration and multiple possible deal structures.
Event Year Begin: 2009
Remicade/Simponi: Confidential Instructions for J&J Business Team
Remicade/Simponi: Confidential Instructions for Merck Business Team
Remicade/Simponi: Confidential Instructions for Merck Legal Team